Evidence map›Paper›PMID 30775425›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2019

Mortality and Exacerbations by Global Initiative for Chronic Obstructive Lung Disease Groups ABCD: 2011 Versus 2017 in the COPDGene® Cohort.

Rachel N Criner, Wassim W Labaki, Elizabeth A Regan, Jessica M Bon, Xavier Soler, Surya P Bhatt, Susan Murray, John E Hokanson, Edwin K Silverman, James D Crapo and 6 more

Abstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Smoking cessation and vaccination.European respiratory review : an official journal of the European Respiratory Society · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Prediction of Mortality Using Different COPD Risk Assessments - A 12-Year Follow-Up.International journal of chronic obstructive pulmonary disease
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Rachel N CrinerDepartment of Internal Medicine, University of Michigan, Ann Arbor.
Wassim W LabakiDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor.
Elizabeth A ReganDivision of Pulmonary Medicine, National Jewish Health, Denver, Colorado.
Jessica M BonDivision of Pulmonary and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Xavier SolerDivision of Pulmonary, Critical Care and Sleep Medicine, University of California, San Diego.
Surya P BhattDivision of Pulmonary, Allergy and Critical Care Medicine, University of Alabama, Birmingham.
Susan MurraySchool of Public Health, University of Michigan, Ann Arbor.
John E HokansonSchool of Public Health, University of Colorado, Aurora.
Edwin K SilvermanChanning Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
James D CrapoDivision of Pulmonary Medicine, National Jewish Health, Denver, Colorado.
Jeffrey L CurtisDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor.
Fernando J MartinezDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor.
Barry J MakeDivision of Pulmonary Medicine, National Jewish Health, Denver, Colorado.
MeiLan K HanDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor.
Carlos H MartinezDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor.
COPDGene® Investigators

Funding

Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
Defining Pathways in COPD Patient Oriented ResearchK24HL138188 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MeiLan K Han · 2017 to 2026
$1.2M
Modulation of Steroid Suppression by Alveolar Macrophage EfferocytosisI01CX000911 · VA · VETERANS HEALTH ADMINISTRATION · PI CURTIS, JEFFREY LOUIS · 2016 to 2020
–
CSRD VA I01 CX000911NHLBI NIH HHS K24 HL138188NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic obstructive pulmonary diseasecopdexacerbation mortalityGlobal initiative for chronic Obstructive Lung Dis

Identifiers

PMID30775425
PMCPMC6373581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.